Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Cheng

Showing results (1481-1490 of 1,544) with videos related to

Pageof 155
Sort By:
Journal of Thoracic Disease|January 7, 2022
Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021Chengshuo Wang, Lei Cheng, Huabin Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 19, 2022
Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates SeizuresMeng-Liu Zeng, Jing-Jing Cheng, Shuo Kong, et al.
BMC Cancer|June 11, 2024
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage studyBo Zhang, Hongyu Liu, Chunlei Shi, et al.
Medcomm|February 20, 2025
Differential expression of the MYC-Notch axis drives divergent responses to the front-line therapy in central and peripheral extensive-stage small-cell lung cancerLibo Luo, Rui Xia, Shiqi Mao, et al.
Oncotarget|February 6, 2016
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese populationLi-Xin Qiu, Lei Cheng, Jing He, et al.
Oncotarget|February 25, 2016
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese populationLi-Xin Qiu, Rui-Xi Hua, Lei Cheng, et al.
Bioactive Materials|June 7, 2021
Novel dental implant modifications with two-staged double benefits for preventing infection and promoting osseointegration <i>in vivo</i> and <i>in vitro</i>Xiaoyu Huang, Yang Ge, Bina Yang, et al.
Nature Communications|August 12, 2018
Programmed cell removal by calreticulin in tissue homeostasis and cancerMingye Feng, Kristopher D Marjon, Fangfang Zhu, et al.
The Lancet. Child & Adolescent Health|February 21, 2026
Children's access to controlled medicines: policy lessons, intervention priorities, and a framework for actionMaria-Belen Tarrafeta-Sayas, Brandon Maser, Ximena García-Quintero, et al.
Parkinsonism & Related Disorders|October 9, 2025
No anti-IgLON5 antibody in carefully diagnosed PSP patients with "atypical" or variant clinical featuresAnis Nadhirah Khairul Anuar, Ai Huey Tan, Jeremy Christopher Fernandiz, et al.
Pageof 155

Showing results (1481-1490 of 1,544) with videos related to

Sort By:
Pageof 155
Journal of Thoracic Disease|January 7, 2022
Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021Chengshuo Wang, Lei Cheng, Huabin Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 19, 2022
Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates SeizuresMeng-Liu Zeng, Jing-Jing Cheng, Shuo Kong, et al.
BMC Cancer|June 11, 2024
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage studyBo Zhang, Hongyu Liu, Chunlei Shi, et al.
Medcomm|February 20, 2025
Differential expression of the MYC-Notch axis drives divergent responses to the front-line therapy in central and peripheral extensive-stage small-cell lung cancerLibo Luo, Rui Xia, Shiqi Mao, et al.
Oncotarget|February 6, 2016
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese populationLi-Xin Qiu, Lei Cheng, Jing He, et al.
Oncotarget|February 25, 2016
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese populationLi-Xin Qiu, Rui-Xi Hua, Lei Cheng, et al.
Bioactive Materials|June 7, 2021
Novel dental implant modifications with two-staged double benefits for preventing infection and promoting osseointegration <i>in vivo</i> and <i>in vitro</i>Xiaoyu Huang, Yang Ge, Bina Yang, et al.
Nature Communications|August 12, 2018
Programmed cell removal by calreticulin in tissue homeostasis and cancerMingye Feng, Kristopher D Marjon, Fangfang Zhu, et al.
The Lancet. Child & Adolescent Health|February 21, 2026
Children's access to controlled medicines: policy lessons, intervention priorities, and a framework for actionMaria-Belen Tarrafeta-Sayas, Brandon Maser, Ximena García-Quintero, et al.
Parkinsonism & Related Disorders|October 9, 2025
No anti-IgLON5 antibody in carefully diagnosed PSP patients with "atypical" or variant clinical featuresAnis Nadhirah Khairul Anuar, Ai Huey Tan, Jeremy Christopher Fernandiz, et al.
Pageof 155